Navigation Links
New drug target for immune diseases discovered
Date:8/3/2010

gerated production of molecules that activate the adaptive immune system and abnormal antibodies, which attack normal cells causing inflammation and tissue damage. This exaggerated production may occur partly as a result of abnormally strong signaling from TACI via MyD88. By analyzing cells and tissues from immunodeficient patients and genetically engineered mice, Dr. Cerutti's team found a previously unknown interaction between TACI and MyD88 that is important for the production of antibodies against infectious agents. Yet, the same interaction may cause the exaggerated immune response in people with autoimmune diseases.

"Our discovery provides a novel specific target, the signaling pathway between TACI and MyD88, to block the overreaction of the immune system and tissue damage in individuals with autoimmune disorders," said Dr. Cerutti. "We look forward to studying this discovery further and developing therapeutic targets that will inhibit the interaction between TACI and MyD88, preventing autoimmune diseases from progressing with fewer side effects than currently prescribed treatments."

Dr. Cerutti's team collaborated with other researchers at Mount Sinai School of Medicine, including Charlotte Cunningham-Rundles, MD, Professor of Medicine and Pediatrics, and Huabao Xiong, PhD, Assistant Professor of Medicine.

According to the National Women's Health Information Center, autoimmune diseases impact 23.5 million Americans. Common examples include lupus, in which the immune system attacks the skin and/or several organs within the body; rheumatoid arthritis, in which the immune system attacks joints; multiple sclerosis, in which the immune system attacks the nervous system; and Type 1diabetes, in which the immune system attacks insulin-producing cells in the pancreas.


'/>"/>

Contact: Mount Sinai Press Office
newsnow@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MSU targets womens health research with $2.5 million grant
2. NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer
3. Researcher targets gene regulators on link between arsenic, cancer
4. Success of community interventions for childhood obesity varies depending on the target age group
5. Radiation device allows for targeted breast radiation to control cancer
6. Targeting flight-or-fight hormone response to combat heart failure
7. Miami meeting on radiation therapy targets patient safety
8. EcoFocus Study Identifies Opportunities for Companies to Target the New 21st Century Mom
9. Surveillance colonoscopy should be targeted to high-risk patients
10. Targeting disease remission has socio-economic benefits over low disease activity
11. Tumor target suggests personalized treatment for melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 2015 , ... On September 9, 2015, over 27,000 people from all over ... convention to date for the state of Utah. , “We are thrilled with the ... David Stirling, doTERRA CEO. “One of the most exciting elements of our convention is ...
(Date:9/2/2015)... ... September 02, 2015 , ... Please join the world ... , which was established by the Foundation in 2007 with the help of ... fund more research remains our top priority,” commented Christine Buckley, Executive Director of ...
(Date:9/2/2015)... ... ... Mobile working is increasingly more important, as business professionals are looking to ... are being launched, and mobile device usage as a whole is something people around ... personal lives. What's more people are expecting mobile versions of their favorite software. , ...
(Date:9/1/2015)... , ... September 01, 2015 , ... September is National ... disease that affects more than 233,000 men each year in the United States. , ... most common non-skin cancer in America, affecting 1 in 7 men. One new case ...
(Date:9/1/2015)... ... 01, 2015 , ... According to a study published August 25th ... participated in a three year study about weight loss and diabetes were far more ... weight loss surgery at the onset of the trial. In fact, the participants in ...
Breaking Medicine News(10 mins):Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... that polymerase chain reaction (PCR) testing for Borrelia burgdorferi ... may confirm the diagnosis of Lyme arthritis, but is ... patients whose arthritis persists after antibiotic therapy. Findings of ... , a journal of the American College of Rheumatology ...
... DENVER According to a new study conducted by researchers ... pulmonary disease (COPD) an effective workout and one that, ... "Our study showed that COPD patients exercised at ... five minutes of specified Wii Fitexercises, indicating the Wii Fit ...
... , MONDAY, May 16 (HealthDay News) -- A chemical ... may pose a health risk, a new study indicates. ... at levels of the chemical, isocyanic acid, in the ... chemical with conventional measurement techniques, explained the U.S. National ...
... , MONDAY, May 16 (HealthDay News) -- Asthma patients ... flares can suffer worse outcomes, including hospitalization. That,s ... patients in two New York City emergency departments. They ... and their attempts at self-management before they decided to ...
... Randy Dotinga HealthDay Reporter , MONDAY, May 16 (HealthDay ... infested by parasites despite clinical evidence to the contrary. Now, ... in the patient,s head -- is often right on target. ... bugs, worms or germs had invaded their skin. In all but ...
... an explanation of how stroke patients can achieve better recovery. ... has proved to benefit recovery during the later phases of ... a hormone that is found in the blood and contributes ... of this hormone are higher in people who exercise regularly ...
Cached Medicine News:Health News:Deer tick bacteria DNA in joint fluid not reliable marker of active lyme arthritis 2Health News:Deer tick bacteria DNA in joint fluid not reliable marker of active lyme arthritis 3Health News:COPD patients may breathe easier, thanks to the Wii 2Health News:COPD patients may breathe easier, thanks to the Wii 3Health News:Chemical in Smoke May Pose Health Risk 2Health News:Don't Delay Emergency Care When Asthma Flare-Ups Strike 2Health News:For Some, Bugs Crawling on Skin Is a Delusion 2Health News:Hormone improves long-term recovery from stroke 2
(Date:9/1/2015)... OAKS, Calif. , Sept. 1, 2015 /PRNewswire/ ... neuroscience collaboration with Novartis in the areas of ... potential entry into Alzheimer,s disease by teaming up ... Alzheimer,s disease program directed at genetically predisposed individuals ... enables Amgen to focus on the commercialization of ...
(Date:9/1/2015)... 2015 Ardelyx, Inc. (NASDAQ: ARDX ... and cardio-renal diseases, today announced that Sanofi notified ... license agreement for Ardelyx,s portfolio of NaP2b inhibitors ... associated with termination and the return of rights. ... entered into an option and license agreement under ...
(Date:9/1/2015)... , Sept. 1, 2015 Emerus Holdings, ... of emergent, inpatient and diagnostic care in partnership ... signed a definitive agreement to receive a strategic ... Carson), a leading health care investment firm. ... high-quality, patient-centric acute episodic and ambulatory clinical services ...
Breaking Medicine Technology:Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
... 2011 Dynatronics Corporation (NASDAQ: DYNT ) today announced ... 2011. Sales for the quarter ended June 30, 2011 ... ended June 30, 2010. Sales for the year ended June 30, ... the prior year. Net income for the quarter ...
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... subsidiary, Valeant International (Barbados) SRL, has received notice that ... oral bile acid sequestrant for hypercholesterolemia, has been approved ... "Cardiovascular Disease is the cause of one in ...
Cached Medicine Technology:Dynatronics Announces Fourth Quarter and Year-end Results 2Dynatronics Announces Fourth Quarter and Year-end Results 3Dynatronics Announces Fourth Quarter and Year-end Results 4Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada 2Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada 3Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: